Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual antiplatelet therapy comparison after PCI in acute coronary syndrome
ChiCTR-OPC-16008963Phase 4Recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of clopidogrel and cilostazol in acute coronary syndrome (ACS), sponsored by Zhongshan Hospital, Fudan University. Primary endpoints: adenosine and cAMP. Started Jan 2016; status: recruiting.
02
Drugs
clopidogrelcilostazol
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on ChiCTR-OPC-16008963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-16008963.